P-79 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody
Title:
P-79 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody
Author:
Yoshikawa, A. Ito, K. Yuki, S. Kawamoto, Y. Saito, R. Yamamura, T. Yagisawa, M. Ishiguro, A. Muto, O. Hatanaka, K. Okuda, H. Sato, A. Sasaki, Y. Nakamura, M. Sasaki, T. Kobayashi, T. Dazai, M. Nakatsumi, H. Ueda, A. Sakata, Y. Komatsu, Y.